Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aurobindo Pharma Ltd.
Swot
Aurobindo Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aurobindo Pharma Ltd. has 14 Strengths, 9 Weaknesses, 6 Opportunities and 4 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(9)
Opportunity
(6)
Threats
(4)
Others
(3)
Value Stocks, Under Radar (DVM)
Jim Slater's Zulu Principle (Discover Growth Stocks)
Consistent Highest Return Stocks over Five Years - Nifty500
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Companies with decreasing Promoter pledge
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Falling Comet (DVM)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Declining Net Cash Flow : Companies not able to generate net cash
Weak Momentum: Price below Short, Medium and Long Term Averages
Increasing Trend in Non-Core Income
RSI indicating price weakness
High promoter stock pledges
Near 52 Week Low
Broker price or reco upgrades in last month
Brokers upgraded recommendation or target price in the past three months
Big Deal (Insider and SAST) buys last month greater than 1% of total shares
Street Favorite: High Analyst Rating with at least 20% upside
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
Broker price or reco upgrades in last month
Red Flags: Firms linked to ongoing regulatory investigations/legal cases
MFs decreased their shareholding last quarter
US FDA Warning Letter
Red Flag: Companies seeing significant coronavirus impact
Rising Delivery Percentage Compared to Prev Day
Indian stocks that could be impacted by Brexit (Britain leaving the EU)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
